01 9Stivarga
02 1StivargaTM
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 575
2019 Revenue in Millions : 497
Growth (%) : 16
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 525
2020 Revenue in Millions : 575
Growth (%) : 0
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 644
2021 Revenue in Millions : 525
Growth (%) : 23
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 567
2022 Revenue in Millions : 644
Growth (%) : -15
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 246
2014 Revenue in Millions : 344
Growth (%) : 40%
Main Therapeutic Indication : Oncology
Currency : USD
2014 Revenue in Millions : 13.70%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 391
2016 Revenue in Millions : 341
Growth (%) : 15
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 356
2017 Revenue in Millions : 356
Growth (%) : 0%
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 292
2015 Revenue in Millions : 332
Growth (%) : -12
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 448
2018 Revenue in Millions : 343
Growth (%) : 30
LOOKING FOR A SUPPLIER?